Skip to main content
. 2021 Mar 9;7(3):e06438. doi: 10.1016/j.heliyon.2021.e06438

Table 3.

Concordance between IM status from the 101-gene model and IO score from the novel immuno-oncology algorithm within the validation cohort of 335 unique TNBC samples.

101-gene TNBC Model
IM+ IM-
IO Algorithm IO+ 82 (24%) 37 (11%)
IO- 2 (1%) 214 (64%)